BioAgilytix is a global contract research organization (CRO) specializing in laboratory services focused on
supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in Durham,
North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany.
BioAgilytix provides small/large molecule pharmacokinetic (PK) and pharmacodynamic (PD), immunogenicity, biomarkers,
molecular biology, flow cytometry, and cell-based assay services supporting the development and release testing of
therapeutics across a number of industries and disease states.
BioAgilytix at each site offers assay development, feasibility, validation, and sample analysis according to GLP, and
GCP/GCLP. In addition, each site offers fit for purpose Biomarker characterization and testing. San Diego and Australia labs
offer small molecule testing. Durham and Germany sites offer GMP quality control testing (i.e., product release testing,
stability testing, potency, etc.). Finally, BioAgilytix also offers CLIA services in the Durham and Morrisville facilities and
diagnostic testing services at its CLIA-certified, CAP-accredited Boston facility. Australia labs also specializes in virology. To know more
Please contact us through the following form : https://www.bioagilytix.com/speak-to-scientist/
